Source:http://linkedlifedata.com/resource/pubmed/id/18182175
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
3
|
pubmed:dateCreated |
2008-4-18
|
pubmed:abstractText |
The transcription factor CCAAT/enhancer binding protein (C/EBP)alpha is a myeloid-specific transcription factor which is required for normal myeloid differentiation. C/EBPalpha is encoded by an intronless gene that is 2783 bp long and maps to human chromosome 19q13.1. C/EBPalpha is a member of the basic region leucine zipper (bZIP) class of DNA-binding proteins. The loss of function of C/EBPalpha has leukemogenic potential. Four types of polymorphisms and 25 mutations (3 already known mutations and 22 novel mutations) were detected in CEBPA (gene for the transcription factor CCAAT/enhancer binding protein (C/EBP) alpha) in analysed samples from 390 patients with myelodysplastic syndrome (MDS) and hematologic malignancies. CEBPA mutations were found in 14/152 (9.2%) of acute myeloid leukemia (AML) patients' samples, 6/143 (4.2%) of MDS patients' samples, 2/56 (3.6%) of non-Hodgkin's lymphoma (NHL) patients' samples and 2/39 (5.1%) of multiple myeloma (MM) patients' samples. No C/EBPalpha mutations were detected in healthy donors (41 individuals). We discuss how these mutations can affect the cellular function of C/EBPalpha and block the myeloid differentiation.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:issn |
1096-0961
|
pubmed:author |
pubmed-author:BenesovaKaterinaK,
pubmed-author:BrezinovaJanaJ,
pubmed-author:CermakJaroslavJ,
pubmed-author:CvekovaPavlaP,
pubmed-author:FuchsOtaO,
pubmed-author:KlamovaHanaH,
pubmed-author:KobylkaPetrP,
pubmed-author:KocovaMarcelaM,
pubmed-author:KosteckaArnostA,
pubmed-author:LemezPetrP,
pubmed-author:MaaloufovaJacquelineJ,
pubmed-author:MarkovaJanaJ,
pubmed-author:NeuwirtovaRadanaR,
pubmed-author:NovakovaLudmilaL,
pubmed-author:ProvaznikovaDanaD,
pubmed-author:SalajPeterP,
pubmed-author:SchwarzJiriJ
|
pubmed:issnType |
Electronic
|
pubmed:volume |
40
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
401-5
|
pubmed:meshHeading |
pubmed-meshheading:18182175-Adult,
pubmed-meshheading:18182175-Aged,
pubmed-meshheading:18182175-Aged, 80 and over,
pubmed-meshheading:18182175-Amino Acid Sequence,
pubmed-meshheading:18182175-CCAAT-Enhancer-Binding Proteins,
pubmed-meshheading:18182175-Female,
pubmed-meshheading:18182175-Humans,
pubmed-meshheading:18182175-Leukemia, Myeloid, Acute,
pubmed-meshheading:18182175-Lymphoma, Non-Hodgkin,
pubmed-meshheading:18182175-Male,
pubmed-meshheading:18182175-Middle Aged,
pubmed-meshheading:18182175-Molecular Sequence Data,
pubmed-meshheading:18182175-Multiple Myeloma,
pubmed-meshheading:18182175-Mutation,
pubmed-meshheading:18182175-Myelodysplastic Syndromes,
pubmed-meshheading:18182175-Polymorphism, Genetic
|
pubmed:articleTitle |
CEBPA polymorphisms and mutations in patients with acute myeloid leukemia, myelodysplastic syndrome, multiple myeloma and non-Hodgkin's lymphoma.
|
pubmed:affiliation |
Institute of Hematology and Blood Transfusion, Department of Cell Physiology, U Nemocnice 1, 128 20 Prague 2, Czech Republic. Ota.Fuchs@uhkt.cz
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|